Hong Kong
Hong Kong
Hong Kong, Hong Kong, China, Hong Kong1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Fibrosis, Fibrosis, Liver, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, cirrhosis of liver, fatty liver disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2026-01-30 | NCT05147090 |